Determining the Platelet Signaling Pathway(s) Critical in Venous Thrombosis Pathogenesis" it might change in the process of editing
确定静脉血栓形成发病机制中至关重要的血小板信号通路”,在编辑过程中可能会发生变化
基本信息
- 批准号:10540297
- 负责人:
- 金额:$ 2.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAdhesivesAffectAgammaglobulinaemia tyrosine kinaseAgeAmericanAnimalsBiological AssayBlood CellsBlood PlateletsBlood VesselsBlood coagulationCardiovascular systemCell AdhesionCellsCessation of lifeClinical TrialsCoagulation ProcessCollagen ReceptorsCytolysisDefectDevelopmentDiseaseG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGoalsGoldGrowthHarvestHemostatic functionHourHumanITAMImpairmentIn VitroIncidenceInferior vena cava structureInflammationInflammatoryInjuryIntegrinsLeadLegLeukocytesLifeLigationMaintenanceMechanicsMegakaryocytesModelingMolecularMonoclonal AntibodiesMusMyocardial InfarctionOutcomePathogenesisPharmacologyPhasePlatelet ActivationPlatelet Count measurementPlatelet aggregationPlayPredispositionPreventionProcessProteinsPulmonary EmbolismRAP1A geneRAS Superfamily ProteinsResolutionRoleSecureSignal PathwaySignal TransductionSignaling MoleculeSiteStandard ModelStenosisStrokeTalinTestingThrombocytopeniaThrombosisThrombusTransgenic MiceVeinsVenousVenous ThrombosisWeightWhole Bloodatherosclerotic plaque rupturebasecombatin vivointravital imagingintravital microscopynew therapeutic targetpreventreceptortherapeutic targetthrombogenesisthromboinflammationvascular inflammationvenous thromboembolism
项目摘要
Project summary
Venous thrombosis (VT) affects close to a million Americans annually. One of the main triggers
of VT is flow restriction, which leads to vascular inflammation and initiation of thrombus
formation. Venous thrombi contain platelets and changes in platelet count correlate with VT
outcome in humans and mice. However, little is known about the molecular mechanisms by
which these cells contribute to venous thrombogenesis. The goal of my project is to
systematically investigate on how major platelet signaling pathways facilitate platelet/leukocyte
adhesion, thrombus growth, and thrombus consolidation following vascular stenosis in mice. My
main hypothesis is that the platelet signaling pathways required during venous thrombogenesis
are similar to those required for securing vascular integrity at sites of inflammation. Specifically,
my study aims to delineate if and how platelet G-protein-coupled receptors (GPCRs),
immunoreceptor tyrosine-based activation motif (ITAM) receptors, and the Rap1-talin1-integrin
signaling axis contribute to VT development in mice. Consistent with my main hypothesis, I
expect ITAM signaling and talin1 to be more important for venous thrombogenesis than GPCRs
and Rap1. The following transgenic mouse lines with documented defects in platelet integrin
signaling will be used: CLEC2 (Clec2fl/flpf4-Cre+), Rap1 (Rap1afl/flRap1bfl/flpf4-Cre+) and
Talin1 (Tln1fl/flpf4-Cre+). Pharmacological inhibition of the collagen receptor, GPVI, the ITAM
signaling molecule, Bruton’s tyrosine kinase (Btk), and 1 and 3 integrins will also be used. In
vivo, VT will be induced by partially ligating the inferior vena cava (IVC stenosis), the gold
standard model for VT studies in mice. Mice will be sacrificed after 48 hrs of flow restriction and
thrombi harvested and weighed. To investigate the role of platelets in the initiation of VT, I will
use intravital imaging of the IVC 2 to 3 hours after ligation and quantify platelet and leukocyte
adhesion to the IVC wall. Whole blood clot contraction and susceptibility to lysis studies will
provide important information on the role of specific platelet signaling pathways during thrombus
consolidation and resolution. Successful completion of the proposed studies will elucidate
platelet signaling pathways that contribute to the initiation, propagation, and stability of venous
thrombi. This information may lead to the identification of new platelet-based therapeutic targets
for the prevention/treatment of VT.
项目摘要
静脉血栓形成(VT)每年影响近一百万美国人。其中一个主要的诱因
室性心动过速的主要原因是血流受限,导致血管炎症和血栓形成
阵静脉血栓含有血小板,血小板计数的变化与VT相关
人类和小鼠的结果。然而,很少有人知道的分子机制,
这些细胞导致静脉血栓形成。我这个项目的目标是
系统研究血小板信号通路如何促进血小板/白细胞
粘附、血栓生长和小鼠血管狭窄后血栓固结。我
主要假设是静脉血栓形成过程中所需的血小板信号通路
类似于在炎症部位确保血管完整性所需的那些。具体地说,
我的研究旨在描述血小板G蛋白偶联受体(GPCRs),
基于酪氨酸的免疫受体激活基序(ITAM)受体和Rap 1-talin 1-整联蛋白
信号传导轴参与小鼠VT的发展。与我的主要假设一致,我
预期ITAM信号和talin 1对静脉血栓形成比GPCR更重要
Rap 1以下转基因小鼠系具有血小板整合素缺陷的记录
将使用信号传导:CLEC 2(Clec 2fl/flpf 4-Cre+)、Rap 1(Rap 1afl/flRap 1bfl/flpf 4-Cre+)和
塔林1(Tln 1fl/flpf 4-Cre+)。胶原蛋白受体、GPVI、ITAM的药理学抑制
也将使用信号分子、布鲁顿酪氨酸激酶(Btk)以及β 1和β 3整联蛋白。在
在体内,VT将通过部分结扎下腔静脉(IVC狭窄)诱导,金
用于小鼠VT研究的标准模型。在48小时的血流限制后处死小鼠,
收获血栓并称重。为了研究血小板在室性心动过速发生中的作用,
在结扎后2至3小时对IVC进行活体成像,并对血小板和白细胞进行定量
粘附于IVC壁。全血凝块收缩和对溶解的敏感性研究将
提供了血栓形成过程中特定血小板信号通路作用的重要信息
巩固和解决。成功完成拟议的研究将阐明
血小板信号通路,有助于静脉血栓的启动、传播和稳定。
血栓这一信息可能导致新的血小板为基础的治疗目标的识别
用于预防/治疗VT。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jean Marie Niyitegeka Mwiza其他文献
Jean Marie Niyitegeka Mwiza的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jean Marie Niyitegeka Mwiza', 18)}}的其他基金
Determining the Platelet Signaling Pathway(s) Critical in Venous Thrombosis Pathogenesis" it might change in the process of editing
确定静脉血栓形成发病机制中至关重要的血小板信号通路”,在编辑过程中可能会发生变化
- 批准号:
10066469 - 财政年份:2021
- 资助金额:
$ 2.94万 - 项目类别:
相似海外基金
I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
- 批准号:
2409620 - 财政年份:2024
- 资助金额:
$ 2.94万 - 项目类别:
Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
- 批准号:
2403716 - 财政年份:2024
- 资助金额:
$ 2.94万 - 项目类别:
Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
- 批准号:
23H01718 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
- 批准号:
EP/W019450/1 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
- 批准号:
10741660 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
- 批准号:
2323317 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
- 批准号:
10062336 - 财政年份:2023
- 资助金额:
$ 2.94万 - 项目类别:
Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
- 批准号:
10677869 - 财政年份:2022
- 资助金额:
$ 2.94万 - 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
- 批准号:
10746743 - 财政年份:2022
- 资助金额:
$ 2.94万 - 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
- 批准号:
10021363 - 财政年份:2022
- 资助金额:
$ 2.94万 - 项目类别:
Investment Accelerator